MedTrace Logo

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

NCT01557842 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-06-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if early ablation (i.e., ablation of ventricular tachycardia in patients with infrequent VT episodes) is more effective than medical therapy alone for the treatment of ischemic ventricular tachycardia in patients with Implantable Cardioverter Defibrillators (ICDs) who continue to have episodes of ventricular tachycardia despite drug therapy.

Conditions

  • Ventricular Tachycardia
  • Ischemic

Interventions

DRUG

Drug Treatment

Class I and III antiarrhythmic drug treatment.

DEVICE

Catheter Ablation

Radiofrequency catheter ablation and Class I and III antiarrhythmic drug treatment.

Sponsors & Collaborators

  • Biosense Webster, Inc.

    lead INDUSTRY

Principal Investigators

  • David Callans, MD · University of Pennsylvania

  • Francis Marchlinski, MD · University of Pennsylvania

  • Andrea Natale, MD · Texas Cardiac Arrhythmia Research Foundation

  • Vivek Reddy, MD · Icahn School of Medicine at Mount Sinai

  • David Wilber, MD · Loyola University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-01
Primary Completion
2014-03-19
Completion
2014-03-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01557842 on ClinicalTrials.gov